NICOLE BETTS: Open Payments
NPI 1417327461 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 17 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $308 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $144 |
| Lundbeck LLC | 5 | $89 |
| ABBVIE INC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| PFIZER INC. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: REXULTI, VRAYLAR, XIFAXAN, Rybelsus, NURTEC ODT, Ozempic, MAVYRET, Belbuca.
Industry payments across CO — which companies pay providers there.
